Perritt Capital Management Inc Has $372,000 Stock Holdings in InfuSystem Holdings, Inc. (NYSE:INFU)

Perritt Capital Management Inc boosted its holdings in shares of InfuSystem Holdings, Inc. (NYSE:INFU) by 14.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 44,000 shares of the company’s stock after purchasing an additional 5,500 shares during the period. Perritt Capital Management Inc’s holdings in InfuSystem were worth $372,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in the stock. BNP Paribas Financial Markets lifted its position in shares of InfuSystem by 66.4% during the 3rd quarter. BNP Paribas Financial Markets now owns 4,076 shares of the company’s stock worth $27,000 after buying an additional 1,626 shares during the period. State Street Corp raised its stake in InfuSystem by 1.1% during the third quarter. State Street Corp now owns 267,012 shares of the company’s stock worth $1,789,000 after acquiring an additional 3,019 shares in the last quarter. JPMorgan Chase & Co. lifted its holdings in shares of InfuSystem by 74.1% during the third quarter. JPMorgan Chase & Co. now owns 15,556 shares of the company’s stock valued at $104,000 after acquiring an additional 6,623 shares during the period. Geode Capital Management LLC lifted its holdings in shares of InfuSystem by 1.8% during the third quarter. Geode Capital Management LLC now owns 436,508 shares of the company’s stock valued at $2,925,000 after acquiring an additional 7,550 shares during the period. Finally, Legato Capital Management LLC acquired a new stake in shares of InfuSystem in the 4th quarter valued at $85,000. 71.13% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the stock. Sidoti raised shares of InfuSystem to a “strong-buy” rating in a report on Tuesday, March 18th. StockNews.com raised shares of InfuSystem from a “buy” rating to a “strong-buy” rating in a report on Friday, March 14th.

InfuSystem Price Performance

InfuSystem stock opened at $5.36 on Wednesday. The business’s fifty day moving average is $7.12 and its two-hundred day moving average is $7.52. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.59 and a current ratio of 1.98. The firm has a market cap of $112.61 million, a P/E ratio of 89.35 and a beta of 1.75. InfuSystem Holdings, Inc. has a 52 week low of $5.26 and a 52 week high of $9.97.

InfuSystem Company Profile

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.